Literature DB >> 18370295

Hematopoietic development of human embryonic stem cells in culture.

Xinghui Tian1, Dan S Kaufman.   

Abstract

The successful isolation and characterization of human embryonic stem cells (hESCs) provides a powerful tool to study the cellular and genetic mechanisms that mediate cell-fate decisions toward distinct developmental lineages. hESC-derived cells may also be suitable for novel cellular therapies. Significant progress in hematopoietic development of hESCs has demonstrated production of many types of blood cells from hESCs including myeloid, erythroid and lymphoid lineage cells, and possibly hematopoietic stem cells. Current established approaches to generate specific hematopoietic lineages are based on the initial pre-differentiation of hESCs into a heterogeneous mixture of cell populations. In this chapter, we describe two methods that have been successfully used in our laboratory: (1) co-culture with stromal cells derived from hematopoietic microenvironments and (2) x embryoid body (EB) formation. Subsequent to this early differentiation step, distinct progenitor cell populations can be derived, sorted, and utilized for further lineage-specific developmental studies.

Entities:  

Mesh:

Year:  2008        PMID: 18370295     DOI: 10.1007/978-1-59745-182-6_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

1.  Human fetal liver stromal cells expressing erythropoietin promote hematopoietic development from human embryonic stem cells.

Authors:  Chao Yang; Lei Ji; Wen Yue; Shuang-Shuang Shi; Ruo-Yong Wang; Yan-Hua Li; Xiao-Yan Xie; Jia-Fei Xi; Li-Juan He; Xue Nan; Xue-Tao Pei
Journal:  Cell Reprogram       Date:  2012-02       Impact factor: 1.987

2.  Induction of fracture repair by mesenchymal cells derived from human embryonic stem cells or bone marrow.

Authors:  Anita Undale; Daniel Fraser; Theresa Hefferan; Ross A Kopher; James Herrick; Glenda L Evans; Xiaodong Li; Sanjeev Kakar; Meredith Hayes; Elizabeth Atkinson; Michael J Yaszemski; Dan S Kaufman; Jennifer J Westendorf; Sundeep Khosla
Journal:  J Orthop Res       Date:  2011-06-14       Impact factor: 3.494

Review 3.  Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion.

Authors:  Z Shu; S Heimfeld; D Gao
Journal:  Bone Marrow Transplant       Date:  2013-09-30       Impact factor: 5.483

4.  Human embryonic stem cell-derived CD34+ cells function as MSC progenitor cells.

Authors:  Ross A Kopher; Vesselin R Penchev; Mohammad S Islam; Katherine L Hill; Sundeep Khosla; Dan S Kaufman
Journal:  Bone       Date:  2010-06-27       Impact factor: 4.398

5.  Bioluminescent imaging demonstrates that transplanted human embryonic stem cell-derived CD34(+) cells preferentially develop into endothelial cells.

Authors:  Xinghui Tian; Melinda K Hexum; Vesselin R Penchev; Russell J Taylor; Leonard D Shultz; Dan S Kaufman
Journal:  Stem Cells       Date:  2009-11       Impact factor: 6.277

6.  Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function.

Authors:  Katherine L Hill; Petra Obrtlikova; Diego F Alvarez; Judy A King; Susan A Keirstead; Jeremy R Allred; Dan S Kaufman
Journal:  Exp Hematol       Date:  2010-01-11       Impact factor: 3.084

7.  Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancer.

Authors:  Nate N Waldron; Dan S Kaufman; Seunguk Oh; Zintis Inde; Melinda K Hexum; John R Ohlfest; Daniel A Vallera
Journal:  Mol Cancer Ther       Date:  2011-08-23       Impact factor: 6.009

8.  Use of RUNX2 expression to identify osteogenic progenitor cells derived from human embryonic stem cells.

Authors:  Li Zou; Fahad K Kidwai; Ross A Kopher; Jason Motl; Cory A Kellum; Jennifer J Westendorf; Dan S Kaufman
Journal:  Stem Cell Reports       Date:  2015-02-10       Impact factor: 7.765

9.  The Telomerase Complex Directly Controls Hematopoietic Stem Cell Differentiation and Senescence in an Induced Pluripotent Stem Cell Model of Telomeropathy.

Authors:  Shyam Sushama Jose; Federico Tidu; Petra Burilova; Tomas Kepak; Kamila Bendickova; Jan Fric
Journal:  Front Genet       Date:  2018-08-29       Impact factor: 4.599

10.  In vivo selection of human embryonic stem cell-derived cells expressing methotrexate-resistant dihydrofolate reductase.

Authors:  J L Gori; X Tian; D Swanson; R Gunther; L D Shultz; R S McIvor; D S Kaufman
Journal:  Gene Ther       Date:  2009-10-15       Impact factor: 5.250

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.